FDA Issued Advisory on Chantix
Filed in archive Cases , Consumer Alert , Treatment by Gloria Gamat on February 5, 2008

The FDA has recently issued a Public Health Advisory on Chantix (varenicline) - alerting health care providers, patients, and caregivers to its new safety warnings.
A product of Pfizer, Chantix is a smoking cessation drug approved by the FDA in May 2006.
The said advisory states that Chantix can indeed be related to changes in behavior, agitation
, depressed mood, suicidal ideation, and actual suicidal behavior.On Nov. 20, 2007, FDA issued an Early Communication to the public and health care providers that the agency was evaluating postmarketing adverse event reports on Chantix related to changes in behavior, agitation, depressed mood, suicidal ideation, and actual suicidal behavior.
As the agency's review of the adverse event reports proceeds, it appears increasingly likely that there may be an association between Chantix and serious neuropsychiatric symptoms. As a result, FDA has requested that Pfizer, the manufacturer of Chantix, elevate the prominence of this safety information to the warnings and precautions section of the Chantix prescribing information, or labeling.
In addition, FDA is working with Pfizer to finalize a Medication Guide for patients. This is an example of FDA working with drug manufacturers throughout products' lifecycles to keep health care professionals and patients informed of new and emerging safety data.
"Chantix has proven to be effective in smokers motivated to quit, but patients and health care professionals need the latest safety information to make an informed decision regarding whether or not to use this product," said Bob Rappaport, M.D., director of the FDA's Division of Anesthesia, Analgesia and Rheumatology Products.
"While Chantix has demonstrated clear evidence of efficacy, it is important to consider these safety concerns and alert the public about these risks. Patients should talk with their doctors about this new information and whether Chantix is the right drug for them, and health care professionals should closely monitor patients for behavior and mood changes if they are taking this drug."
The best thing to do is still discuss this carefully with your doctor to find out if Chantix is good for you.
[Photo Credit]
Permalink: FDA Issued Advisory on Chantix
Tags:
neuropsychiatric
symptoms
Chantix
smoking
cessation
drug
health
contact+lenses
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/112920

Mr Wong

